{"task_id": "d3a406d1fc75f220", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 231/905)", "text": "ro-\nosteo lysis.\n\u00a9Dr I Maddison \nmyweb.lsbu.ac.uk.\n\n--- Page 237 ---\n223\nEndocrinology\nIn MEN syndromes there are functioning hormone-producing tumours in multiple \norgans (they are inherited as autosomal dominants).20 They comprise: \u2022MEN-1 and 2 \n\u2022Neuro\ufb01 bromatosis (p514) \u2022Von Hippel\u2013Lindau and Peutz\u2013Jeghers syndromes \n(p712 & p708) \u2022Carney complex (spotty skin pigmentation, schwannomas, myxoma \nof skin, mucosa, or heart, especially atrial myxoma), and endo crine tumours: eg \npituit ary adenoma, adrenal hyperplasia, and testicular tumour. \nMEN-1:\n  \n\u2022 Parathyroid hyperplasia/adenoma (~95%; most \ue000Ca\n2+).\n  \n\u2022 Pancreas endocrine tumours (70%)\u2014gastrin oma (p716) or insulinoma (p215), or, \nrarely, somatostatin oma (DM + steatorrhoea + gallstones/cholangitis), VIPoma \n(p258), or gluc agonomas (\u00b1glucagon syndrome: migrating rash; glossitis; cheili-\ntis, \ufb01 g 8.5 p327; an aemia; \ue001weight; \ue000plasma glucagon; \ue000glucose). \n  \n\u2022 Pituitary prolactinoma (~50%) or GH secreting tumour (acromegaly:21 p239); also, \nadrenal and carcinoid tumours are associated.\nThe MEN-1 gene is a tum our suppressor gene. Menin, its protein, alters trans cription \nactivation. Many are sporadic, presenting in the 3rd\u20135th decades.\nMEN-2a:\n  \n\u2022 Thyroid: medullary thyroid carcinoma (seen in ~100%, p600).\n  \n\u2022 Adrenal: phaeochromocytoma (~50%, usually benign and bilateral).\n  \n\u2022 Parathyroid hyperplasia (~80%, but less than 20% have \ue000Ca\n2+). \nMEN-2b: Has similar features to MEN-2a plus mucosal neuromas and Marfanoid \nappearance (p706), but no hyper parathyroidism. Mucosal neuromas consist of \n\u2018bumps\u2019 on: lips, cheeks, tongue, glottis, eyelids, and vis ible corneal nerves. \nThe gene involved in MEN-2a and b is the ret proto-oncogene, a receptor tyrosine \nkinase. Tests for ret mutations are revol ution izing MEN-2 treatment by enabling a \nprophylactic thyroidectomy to be done before neoplasia occurs, usually before \n3yrs of age. NB: ret mutations rarely contribute to sporadic parathyroid tumours.\nMultiple endocrine neoplasia (MEN types 1, 2a, and 2b)\nAutoimmune disorders cluster into two de\ufb01 ned syndromes:\nType 1 Autosomal recessive, rare.\nCause: Mutations of AIRE (Auto ImmuneREgulator) gene on chromosome 21.\nFeatures: \u2022Addison\u2019s disease. \u2022Chronic mucocutaneous candidiasis. \u2022Hypo-\nparathyroidism. Also associated with hypogonadism, pernicious anaemia, autoim-\nmune primary hypothyroidism, chronic active hepatitis, vitiligo, alopecia.\nType 2 HLA D3 and D4 linked, common. Cause: Polygenic.\nFeatures: \u2022Addison\u2019s disease. \u2022Type 1 diabetes mellitus (in 20%).\n  \n\u2022 Autoimmune thyroid disease\u2014hypothyroidism or Graves\u2019 disease.\nAlso associated with primary hypogonadism, vitiligo, alopecia, pernicious anae-\nmia, chronic atrophic gastritis, coeliac disease, dermatitis herpetiformis.\nAutoimmune polyendocrine syndromes\nFig 5.19 Cerebral calci\ufb01 cation in pseudohypopara thyroid-\nism: periventricular (left) and basal ganglia (right). \nCourtesy of Professor Peter Scally.\nFig 5.18 Pseudohypopara-\nthyroidism: short 4th and 5th \nmetacarpals.", "text_length": 3028, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 231/905)", "type": "chunk", "chunk_index": 230, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:52.387265", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:52.388111", "status": "complete", "chunks_added": 2}